<DOC>
	<DOCNO>NCT02130453</DOCNO>
	<brief_summary>The goal clinical research study compare regadenoson nuclear stress test echocardiography strain measurement ( ultrasound image method measure hearts function ) detect coronary artery disease .</brief_summary>
	<brief_title>Accuracy Echo-Stress Protocol Using Regadenoson With Speckle Tracking</brief_title>
	<detailed_description>If agree take part study , echocardiography strain measurement perform . This do lie exam table . An ultrasound technician apply vaseline-like gel chest take measurement hold transducer ( device resembles microphone ) chest , slide back forth . This take 10 minute . After rest strain measurement do , first set nuclear image . This do like echocardiography strain measurement . Once image complete , give regadenoson vein 10 second . Within 2 4 minute receive regadenoson , measurement repeat . These measurement take 2 minute complete . At 30 minute regadenoson give , final image nuclear portion test ( usual timing nuclear image regadenoson ) . You receive treatment stress test , include amount regadenoson , would take part study . Some participant may ask allow repeat strain measurement include additional dose regadenoson first set image good enough additional image may take . Length Study : Your participation study 30 day test OR surgery , whichever occurs later . Researchers collect information medical record 30 day test . If surgery hospitalize 30 day test , call ask problem . This call take 10 minute . This investigational study . Regadenoson FDA approve routinely use nuclear perfusion stress test . The use strain measurement echocardiogram detect coronary disease investigational . Up 300 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>1 . Cancer patient schedule ( perfusion ) nuclear stress test use regadenoson stress agent . 2 . Indications stress test either : part preoperative evaluation prior plan cancer relate surgery consider least intermediate risk ( Intraperitoneal , intrathoracic , head neck surgery , orthopedic prostate surgery ) OR evaluation cardiology clinic symptom describe cardiology consult typical angina , significant suspicion coronary disease symptom describe likely cardiac/coronary etiology . 3 . Patients history LV dysfunction still candidate enrollment study document LVEF recovery ( recent document LVEF 50 % high ) least 6 month prior SPECT regardless current cardiac medication regimen . 4 . Age 18 80 year . 1 . Patients consent trial baseline 2D study poor acoustic echo window ( i.e . reader unable see definition 2 segment apical view ) eligible continue trial peak hyperemia image obtain . 2 . Any patient tachycardia define HR 100 high day SPECT eligible study . 3 . Second third degree AV block . 4 . Sinus node dysfunction . 5 . Patients allergy regadenoson . 6 . Patients LBBB and/or artificial pacemaker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ischemia</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Nuclear stress test</keyword>
	<keyword>Stress Echocardiogram</keyword>
	<keyword>Echocardiography strain measurement</keyword>
	<keyword>Ultrasound cardiac imaging</keyword>
	<keyword>ReSTE</keyword>
	<keyword>SPECT</keyword>
	<keyword>Regadenoson</keyword>
</DOC>